RSS Context Therapeutics Appoints Andy Pasternak As Board Chairman

Currently reading:
 RSS Context Therapeutics Appoints Andy Pasternak As Board Chairman

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
12,187
Likes
1,923
Credits
33,750©
Cash
0$
Context Therapeutics Inc. (CNTX), a biopharmaceutical firm, announced on Monday the appointment of Andy Pasternak as the new Chairman of its Board of Directors. Pasternak takes over from Richard Berman, who resigned from the Board on January 12.

Prior to this role, Pasternak held the position of Executive Vice President and Chief Strategy Officer at Horizon Therapeutics, a company noted for its focus on treatments for serious and rare autoimmune disorders.

As of now, CNTX shares are trading at $1.05 on the Nasdaq, marking a decline of 2.78 percent or $0.03.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips
Top Bottom